Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Dr. McFarland to Speak at University of Arizona October 27

<< Previous

Bullboard Posts

Next >>

Comment by Pandoraon Sep 30, 2022 6:00pm

194 Views

Post# 34998644

RE:Dr. McFarland to Speak at University of Arizona October 27

Eoganacht wrote: CBC Colloquium: "Tackling Cancer and Infection with Light-Responsive Molecules"

Thu, 10/27/2022 - 3:30 pm to 4:30 pm

Abstract: Photomedicine is an interdisciplinary field where chemistry and light meet to fight disease. Photodynamic therapy (PDT) is a special branch of photomedicine that employs a sensitizer molecule, light, and oxygen to destroy target cells with spatiotemporal selectivity. Using a multidisciplinary approach, we have introduced both synthetic compounds and natural products as photosensitizers for PDT. Both have successfully completed Phase 1 clinical trials and are currently in Phase 2 clinical trials. This seminar will share some of our stories in developing metallodrug photosensitizers for treating bladder cancer and photoactive plant extracts for improving oral health. If time permits, some new directions will be highlighted.

LOCATION

Koffler - Room 218

PRESENTER

Dr. Sherri McFarland Professor, Department of Chemistry University of Texas at Arlington

Hosted by: Dr. Elisa Tomat